Revenue
6.91 million USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 6914000 USD Source
Market value
$64.16M
17,178,786 shares as of 2026-11-05, at $3.735 a share (VRCA, IEX close on 2026-11-12) Primary-source evidence
Annual consolidated revenue for 2025: about USD 35.58M, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2024, was about USD 7.566M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-22.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
6.91 million USD
2026 Q3 · USD
-175.98%
2026 Q3 · %
-9.1 million USD
2026 Q3 · USD
14400000 USD
17178786 shares
81.02% · 7.69 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
22.9 million USD
2025-10-01 – 2026-09-30
-43.3 million USD
2025-10-01 – 2026-09-30
-32.1 million USD
2025-10-01 – 2026-09-30
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-13.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 7.57 million
–
Current period
USD 35.58 million
–
35577000 − 7566000 = 28011000 USD
7566000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source35577000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 76.58 million
–
Current period
−USD 17.89 million
–
-17886000 − -76579000 = 58693000 USD
-76579000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-17886000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 60.93 million
–
Current period
−USD 17.6 million
–
-17600000 − -60927000 = 43327000 USD
-60927000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-17600000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 27,000
–
Current period
USD 0
–
0 − 27000 = -27000 USD
27000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source0 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | 12000000 | 42908000 Derived | -30908000 | 4172000 Derived | -35080000 | -28465000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 9032000 | 30328000 Derived | -21296000 | 3191000 Derived | -24487000 | -18952000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 5124000 | 70883000 Derived | -65759000 | 1236000 Derived | -66995000 | -38939000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 7566000 | 73485000 Derived | -65919000 | 10660000 Derived | -76579000 | -60954000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 35577000 | 47762000 Derived | -12185000 | 5701000 Derived | -17886000 | -17600000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Revenue | 12000000 |
|
| 2022 | Revenue | 9032000 |
|
| 2023 | Revenue | 5124000 |
|
| 2024 | Revenue | 7566000 |
|
| 2025 | Revenue | 35577000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | -24.7% |
|
| 2023 | Year over year | -43.3% |
|
| 2024 | Year over year | 47.7% |
|
| 2025 | Year over year | 370.2% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Operating margin | -257.6% |
|
| 2022 | Operating margin | -235.8% |
|
| 2023 | Operating margin | -1,283.4% |
|
| 2024 | Operating margin | -871.3% |
|
| 2025 | Operating margin | -34.2% |
|
| 2021 | Net margin | -292.3% |
|
| 2022 | Net margin | -271.1% |
|
| 2023 | Net margin | -1,307.5% |
|
| 2024 | Net margin | -1,012.1% |
|
| 2025 | Net margin | -50.3% |
|
| 2021 | Free cash flow margin | -237.2% |
|
| 2022 | Free cash flow margin | -209.8% |
|
| 2023 | Free cash flow margin | -759.9% |
|
| 2024 | Free cash flow margin | -805.6% |
|
| 2025 | Free cash flow margin | -49.5% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Operating cash flow | -27582000 |
|
| 2022 | Operating cash flow | -18650000 |
|
| 2023 | Operating cash flow | -38577000 |
|
| 2024 | Operating cash flow | -60927000 |
|
| 2025 | Operating cash flow | -17600000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Free cash flow | -28465000 |
|
| 2022 | Free cash flow | -18952000 |
|
| 2023 | Free cash flow | -38939000 |
|
| 2024 | Free cash flow | -60954000 |
|
| 2025 | Free cash flow | -17600000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Liabilities / assets | 59.3% |
|
| 2022 | Liabilities / assets | 10.5% |
|
| 2023 | Liabilities / assets | 75.8% |
|
| 2024 | Liabilities / assets | 118.2% |
|
| 2025 | Liabilities / assets | 47.5% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Current assets / current liabilities | 1.61× |
|
| 2022 | Current assets / current liabilities | 11.31× |
|
| 2023 | Current assets / current liabilities | 4.55× |
|
| 2024 | Current assets / current liabilities | 1.76× |
|
| 2025 | Current assets / current liabilities | 2.59× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2017-01-01 – 2017-12-31 | −USD 4.46 million Exact valueExact value: -4459000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.58 million Exact valueExact value: -4583000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | −USD 20.65 million Exact valueExact value: -20648000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.87 million Exact valueExact value: -17874000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 774,000 Exact valueExact value: 774000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.65 million Calculation and evidence-17874000 − 774000 USD Exact free cash flow: -18648000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 28.21 million Exact valueExact value: -28207000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 27.41 million Exact valueExact value: -27408000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 682,000 Exact valueExact value: 682000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 28.09 million Calculation and evidence-27408000 − 682000 USD Exact free cash flow: -28090000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 42.69 million Exact valueExact value: -42694000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 30.21 million Exact valueExact value: -30207000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.47 million Exact valueExact value: 1470000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 31.68 million Calculation and evidence-30207000 − 1470000 USD Exact free cash flow: -31677000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 35.08 million Exact valueExact value: -35080000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 27.58 million Exact valueExact value: -27582000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 883,000 Exact valueExact value: 883000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 28.47 million Calculation and evidence-27582000 − 883000 USD Exact free cash flow: -28465000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 24.49 million Exact valueExact value: -24487000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.65 million Exact valueExact value: -18650000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 302,000 Exact valueExact value: 302000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.95 million Calculation and evidence-18650000 − 302000 USD Exact free cash flow: -18952000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 67 million Exact valueExact value: -66995000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 38.58 million Exact valueExact value: -38577000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 362,000 Exact valueExact value: 362000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 38.94 million Calculation and evidence-38577000 − 362000 USD Exact free cash flow: -38939000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 76.58 million Exact valueExact value: -76579000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 60.93 million Exact valueExact value: -60927000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 27,000 Exact valueExact value: 27000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 60.95 million Calculation and evidence-60927000 − 27000 USD Exact free cash flow: -60954000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 17.89 million Exact valueExact value: -17886000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.6 million Exact valueExact value: -17600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.6 million Calculation and evidence-17600000 − 0 USD Exact free cash flow: -17600000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
63 filings · 2,382 latest values · 2,382 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001660334, 1660334, VRCA, edgar:1660334
Also known as Verrica Pharmaceuticals Inc.